NANO-X IMAGING LTD

NNOX ·Healthcare, Medical Devices, Israel
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021
Revenue $13.0M $11.3M $9.9M $8.6M $1.3M
Cost of Revenue $25.8M $21.9M $16.5M $15.5M $2.8M
Gross Profit $-12.8M $-10.6M $-6.6M $-6.9M $-1.5M
Gross Margin -98.2% -94.0% -66.6% -80.2% -116.0%
Operating Expenses
Research & Development $19.2M $20.2M $26.0M $26.5M $17.1M
SG&A Expense $21.6M $22.5M $24.3M $41.3M $34.7M
Operating Income $-78.2M $-56.7M $-62.6M $-117.7M $-61.6M
Operating Margin -600.8% -502.9% -631.9% -1,372.2% -4,720.7%
Interest Expense — — — — —
Pretax Income $-76.8M $-53.9M $-61.1M $-116.9M $-61.8M
Income Tax Expense $-1.8M $-358.0K $-339.0K $-3.7M $-48.0K
Net Income $-75.0M $-53.5M $-60.8M $-113.2M $-61.8M
Net Margin -576.1% -474.3% -613.6% -1,320.2% -4,739.1%
EPS (Basic) $-1.16 $-0.91 $-1.08 $-2.17 $0.00
EPS (Diluted) $-1.16 $-0.91 $-1.08 $-2.17 $0.00
Shares Outstanding (Basic) 64.8K 58.7M 56.4M 52.2M 52.2M
Shares Outstanding (Diluted) 64.8K 58.7M 56.4M 52.2M 52.2M
Dividends Per Share — — — — —